| Predicate |
Object |
| contentType |
Review|Journal Article |
| endingPage |
218 |
| issn |
2150-0878 |
| issueIdentifier |
2 |
| pageRange |
209-218 |
| publicationName |
Journal of the Advanced Practitioner in Oncology |
| startingPage |
209 |
| bibliographicCitation |
Hood K, Shah A. Belinostat for Relapsed or Refractory Peripheral T-Cell Lymphoma. J Adv Pract Oncol. 2016 Mar;7(2):209–18. PMID: 28090369; PMCID: PMC5226312. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_abd97533eb761ac2d7c33567c71b058d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_88e1bcad3e9e37156976c28357a61eb1 |
| date |
2016-03-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://pubmed.ncbi.nlm.nih.gov/28090369
https://doi.org/10.6004/jadpro.2016.7.2.6
https://pubmed.ncbi.nlm.nih.gov/PMC5226312 |
| isPartOf |
https://portal.issn.org/resource/ISSN/2150-0878
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/41396 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Belinostat for Relapsed or Refractory Peripheral T-Cell Lymphoma |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918638
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9861 |